For copies of the latest and previous versions of documents distributed for this trial, please contact the KETO-Lung Trial Office.
Trial overview
Chief Investigator: Professor Gary Middleton
Sponsor: University of Birmingham
Funder: Cancer Research UK
Disease Site: Squamous cell lung cancer (LUSC)
Trial Type: Clinical Trial of a Non-Investigational Medicinal Product
Status: Recruiting
IRAS Number: 333096
Recruitment Start Date: 27-Nov-2024
Anticipated Recruitment End Date: 27-Jun-2026
ISRCTN 73427832
CRCTU Trial Management Team: Early Drug Development Team
Trial Email Address: Keto-lung@trials.bham.ac.uk